Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
EBE-A22 is a derivative of PD 153035
BQ-788 potently and competitively inhibits 125I-labeled ET-1 binding to ETB receptors in human Girrardi heart cells with an IC50 of 1
InChiKey: BNFAYJPQCPZQND-UHFFFAOYSA-N
Chemical Name: 3-[(2E)-3-(4-methoxyphenyl)prop-2-enoyl]-6-methyl-4-phenyl-1
Dosing concentration of Atglistatin is 200 μmol/kg
JH-RE-06 Size:Contact [email protected] for quotation EBE-A22 is a derivative ofJH RE 06, a potent REV1 REV7 interface inhibitor (IC50=0. 78 M; Kd=0. 42 M), targets REV1 that interacts with the REV7 subunit of POL. JH RE 06 disrupts mutagenic translesion synthesis (TLS) by preventing recruitment of mutagenic POL. JH RE 06 improves chemotherapy. Product information CAS Number: 1361227 90 8 Molecular Weight: 468. 72 Formula: C20H16Cl3N3O4 Chemical Name: 8 chloro 2 [(2,4 dichlorophenyl)amino] 3 (3 methylbutanoyl) 5 nitro 1,4
US$ 54.99
US$ 18.00
US$ 137.50
US$ 247.50
US$ 24.99
US$ 59.99
US$ 155.00